Overview

This lecture introduces Psychosis and the Schizophrenia Spectrum and Other Psychotic Disorders category of the DSM-5-TR. It covers the definition and key features of psychosis, the DSM-5-TR diagnostic criteria and specifiers for schizophrenia, the eight disorders on the psychotic spectrum with their distinguishing features, the prevalence and social/economic cost of schizophrenia in Aotearoa New Zealand, how psychosis is assessed and screened for, and the broad categories of treatment and management.

What is psychosis?

The American Psychological Association defines psychosis as an abnormal mental state involving significant problems with reality testing, characterised by serious impairments or disruptions in the most fundamental higher brain functions (perception, cognition and cognitive processing, and emotions/affect), manifested behaviourally as delusions, hallucinations, and significantly disorganised speech.

The five key features that define psychosis:

  • Delusions
  • Hallucinations
  • Disorganized thinking (speech)
  • Grossly disorganized or abnormal motor behaviour (including catatonia)
  • Negative symptoms

[slide does not elaborate individual definitions of delusions or hallucinations beyond naming them as key features; a “Delusions” explainer graphic was referenced but its caption text was illegible]

DSM-5-TR classification: Schizophrenia Spectrum and Other Psychotic Disorders

Eight disorders sit under this DSM-5-TR category:

  • Schizotypal PD
  • Delusional Disorder — subtypes: erotomanic, grandiose, jealous, persecutory, somatic
  • Brief Psychotic Disorder — subtypes: with marked stressor, without marked stressor, postpartum
  • Schizophreniform Disorder
  • Schizophrenia
  • Schizoaffective Disorder
  • Substance induced (psychotic disorder)
  • Catatonia — subtypes: with another disorder, medical condition, unspecified

DSM-5-TR diagnostic criteria for Schizophrenia

Criterion A — two (or more) of the following, each present for a significant portion of a 1-month period (or less if successfully treated), with at least one being (1), (2), or (3):

  1. Delusions
  2. Hallucinations
  3. Disorganized speech (e.g. frequent derailment or incoherence)
  4. Grossly disorganized or catatonic behaviour
  5. Negative symptoms (diminished emotional expression or avolition)

Criterion B — since onset, functioning in one or more major areas (work, interpersonal relations, self-care) is markedly below the level achieved before onset, or (if onset in childhood/adolescence) there is failure to reach the expected level of interpersonal, academic, or occupational functioning.

Criterion C — continuous signs persist for at least 6 months, including at least 1 month of active-phase (Criterion A) symptoms; may include prodromal or residual periods with only negative symptoms, or attenuated positive symptoms (e.g. odd beliefs, unusual perceptual experiences).

Criterion D — schizoaffective disorder and depressive/bipolar disorder with psychotic features are ruled out, because either no major mood episodes occurred concurrently with active-phase symptoms, or mood episodes were present for only a minority of the total illness duration.

Criterion E — the disturbance is not attributable to the physiological effects of a substance or another medical condition.

Criterion F — with a history of autism spectrum disorder or a childhood-onset communication disorder, schizophrenia is additionally diagnosed only if prominent delusions or hallucinations, plus the other required symptoms, are present for at least 1 month (or less if successfully treated).

Course specifiers (used only after 1 year of illness, where consistent with the course criteria):

  • First episode, currently in acute episode
  • First episode, currently in partial remission
  • First episode, currently in full remission
  • Multiple episodes, currently in acute episode
  • Multiple episodes, currently in partial remission
  • Multiple episodes, currently in full remission
  • Continuous
  • Unspecified

Other specifiers:

  • With catatonia (coding note: additional code 293.89/F06.1 for catatonia associated with schizophrenia)
  • Current severity: each of delusions, hallucinations, disorganized speech, abnormal psychomotor behaviour, and negative symptoms is rated on a 5-point scale (0 = not present, 4 = present and severe) based on the most severe presentation in the last 7 days; the diagnosis of schizophrenia can be made without using this severity specifier.

Symptom clusters of Schizophrenia

  • Reality distortion: delusions; hallucinations
  • Psychomotor poverty: lack of effective responsiveness; loss of drive or volition; poverty of speech and movement
  • Disorganisation: inappropriate affect; incoherent speech; disorganised behaviour
  • Cognitive domain (impaired): attention and concentration; memory and learning; executive functioning (including abstract thinking and problem-solving)

Differential diagnosis of Schizophrenia

Before diagnosing schizophrenia, rule out:

  • Delirium
  • Dementia (especially in older patients)
  • Depression
  • Side effects of medication (e.g. heavy sedation)
  • Learning disability
  • Intoxication or withdrawal from psychoactive substances
  • Psychosis due to a general medical condition (e.g. cerebral infections, HIV/AIDS, neurosyphilis, brain trauma, other neurodegenerative disorders)
  • Psychoactive substance-induced psychotic disorder
  • Culture-specific presentations/disorders
  • Other mental disorders: delusional disorder, schizoaffective disorder, bipolar disorder, depressive disorder with psychotic features, schizophreniform disorder, brief psychotic disorder

Culture-specific presentations must always be considered, especially in Aotearoa New Zealand — bpacnz's "Māori Mental Health" resource is given as further reading on this point.

Prevalence, impact and cost of Schizophrenia in Aotearoa NZ

Based on a national cohort study (Gibb, Brewer & Bowden, NZMJ 2021) using linked administrative data. [flag: source abstract text was rendered small in the slide image; figures transcribed to the best of legibility]

Prevalence (2015): 18,096 people living with schizophrenia in NZ overall, 6.7 per 1,000.

  • Sex: male 11,577 (8.9/1,000, reference group); female 6,519 (4.7/1,000)
  • Ethnicity: European 11,730 (6.3/1,000); Māori 6,624 (16.7/1,000); Pacific 2,106 (10.9/1,000); Asian 1,065 (3.0/1,000)
  • Age: 18–24: 1,068 (2.5/1,000); 25–34 (reference): 3,582 (6.5/1,000); 35–44: 4,854 (8.9/1,000); 45–54: 5,169 (8.2/1,000); 55–64: 3,423 (6.3/1,000)

Outcomes, schizophrenia population (N=15,639) vs matched non-schizophrenia population (N=15,639):

  • Health: non-mental-health inpatient stay 13.0% vs 11.2% (OR 1.18 for physical health hospitalisation); mental health inpatient stay 12.2% vs 0.3% (OR 52.80); ED visit 6.7% vs 3.0%; ACC compensation 16.3% vs 29.8%
  • Social support: any welfare benefit 78.8% vs 17.4% (OR 17.64); social housing 13.2% vs 4.3%
  • Justice: police proceedings 9.4% vs 4.6%; conviction 4.7% vs 2.7%; prison sentence 2.3% vs 0.9%
  • Economic: employed 27.6% vs 78.2% (OR 0.11); any income 91.0% vs 80.7%; mean income 44,092 (a difference of $26,226 lower); mean NZDep13 decile 7.4 vs 5.9 (greater deprivation)

Per-person government costs: health 2,486; social support 2,845; justice sector 431; total government cost 5,762.

Summary of the Psychotic Spectrum Disorders

DisorderKey symptomsWorldwide prevalenceAge of onset
Schizophrenia≥2 psychotic symptoms, ≥1 must be delusions or hallucinations, lasting ≥6 months~1%Males 18–24, Females 24–35
Delusional Disorder≥1 non-bizarre delusion(s) continuing ≥1 month~0.003%Late adulthood
Brief Psychotic Disorder≥1 psychotic symptoms (≥1 must be delusions or hallucinations), lasting <1 month~9% of all new psychosis casesMales 18–24, Females 24–35
Schizoaffective DisorderManic or depressive episode concurrent with psychotic symptom(s)~0.32%Early adulthood
CatatoniaBehavioural abnormalities including motoric immobility or excitement; 20–50% of catatonia cases relate to mood disorders, 10% to schizophrenia—Early adulthood
Substance induced psychosisPsychotic symptom onset traceable to starting/stopping a substance~36.5% among methamphetamine misusersEarly adulthood
Schizophreniform DisorderSame symptoms as schizophrenia, lasting >1 month and <6 months~0.4–1%Males 18–24, Females 18–24
Schizotypal PDDifficulty forming/maintaining close interpersonal relationships plus eccentric behaviour~3.9%Late adolescence

A photograph of a person pressed against a wall in a fixed, unusual posture followed the classification slide when it was focused on catatonia, but the slide carried no caption or label, so its intended clinical point (presumably illustrating catatonic posturing) is not stated on the slide.

Assessment and screening

Psychosis is assessed for using:

  • Medical exam
  • Mental State Exam
  • In-depth history
  • Collateral information

Cautions during assessment:

  • Consider culture-specific/appropriate phenomena
  • Be aware of stigma
  • Rule out other possible medical explanations
  • Discuss with a colleague/superior

Differential diagnosis flowchart for confused or disturbed behaviour (Baumann, 2015):

  1. Confused or disturbed behaviour → is there a fluctuating level of consciousness?
    • Yes → Delirium → toxic exposure? Yes → intoxication/withdrawal from substance abuse or prescribed medication. No → general medical conditions (e.g. infections, trauma, epilepsy, cardiovascular disorders, metabolic disorders, endocrine disorders, organ failure, deficiency states)
    • No → Cognitive impairment → since birth? Yes → intellectual disability. No → dementias
  2. Also assess: psychotic symptoms present?
    • Yes → elevated or depressed mood? Yes → mania or agitated depression. No → schizophrenia spectrum disorders
    • No → pattern of disturbed behaviour since childhood/adolescence? Yes → conduct/personality disorders. No → reaction to stress/life events? Yes → PTSD/adjustment disorders/dissociative states. No → fear & panic/anxiety disorders/depression

Treatment and management

Management of psychosis and schizophrenia is multidisciplinary, spanning:

  • Medication (pharmacotherapy): antipsychotics, antidepressants, mood stabilisers
  • Psychological treatment (psychotherapy): CBT, family therapy, social skills training, group therapy, psycho-education
  • Nursing
  • Social work: social interventions
  • Occupational therapy: occupational interventions, educational interventions
  • Culture-specific interventions
  • Spiritual interventions

Key summary points

  • Psychotic spectrum disorders might be uncommon, but they do present in clinical practice.
  • They are often highly distressing and debilitating conditions.
  • Doctors need to know what they are, and be able to assess/screen, diagnose, and treat them or refer when they encounter them.
  • Diagnosis can be challenging, as many symptoms can also present as part of other conditions, making screening and assessment critical for an accurate diagnosis.

Self-test

  1. Define psychosis according to the APA.
  2. List the five key features that define psychosis.
  3. List the eight disorders under the DSM-5-TR’s Schizophrenia Spectrum and Other Psychotic Disorders category, including delusional disorder’s five subtypes.
  4. State DSM-5-TR Criterion A for schizophrenia, and identify which symptoms alone are sufficient to help meet it.
  5. Describe DSM-5-TR Criteria B, C, D, E and F for a diagnosis of schizophrenia.
  6. List the DSM-5-TR course specifiers available for schizophrenia (used after 1 year of illness duration).
  7. Describe how current severity is specified for schizophrenia.
  8. List the four symptom clusters of schizophrenia, with one feature of each.
  9. List the conditions that must be ruled out before diagnosing schizophrenia.
  10. What was the prevalence of schizophrenia in NZ in 2015 overall, and how did it differ by ethnicity?
  11. Describe how health, social, justice and economic outcomes differed between people with schizophrenia and a matched comparison population in the NZ cohort study.
  12. Distinguish delusional disorder, brief psychotic disorder and schizophreniform disorder from schizophrenia in terms of duration and required symptoms.
  13. Distinguish schizoaffective disorder from schizophrenia.
  14. Describe catatonia, including its typical associations with other conditions.
  15. List the four methods used to assess for psychosis, and the cautions to bear in mind while doing so.
  16. A patient presents with confused, disturbed behaviour. Using the differential diagnosis flowchart, describe how you would distinguish delirium, dementia and a schizophrenia spectrum disorder as possible causes.
  17. List the seven categories of treatment/management for psychosis and schizophrenia, with an example intervention from each.
  18. Why is diagnosing psychotic spectrum disorders described as challenging, and why does this make screening and assessment critical?

Answers